Literature DB >> 4935627

Treatment of duodenal ulcer with glycyrrhizinic-acid-reduced liquorice. A multicentre trial.

.   

Abstract

A double-blind controlled therapeutic trial of glycyrrhizinic-acid-reduced liquorice 760 mg thrice daily for six weeks was carried out on 90 men with relapse of chronic duodenal ulcer. Effects of treatment were judged by the frequency and severity of pain, the amount of alkali consumed, and the doctors' and patients' rating of the clinical response. The results do not show any advantage for the active treatment when compared with the placebo.

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4935627      PMCID： PMC1800461     

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  4 in total

1.  A trial of deglycyrrhizinated liquorice in the treatment of duodenal ulcer.

Authors:  H Feldman; T Gilat
Journal:  Gut       Date:  1971-06       Impact factor: 23.059

2.  Clinical trial of deglycyrrhizinized liquorice in gastric ulcer.

Authors:  A G Turpie; J Runcie; T J Thomson
Journal:  Gut       Date:  1969-04       Impact factor: 23.059

3.  Some experience with deglycyrrhizinated liquorice in the treatment of gastric and duodenal ulcers with special reference to its spasmolytic effect.

Authors:  S N Tewari; F C Trembalowicz
Journal:  Gut       Date:  1968-02       Impact factor: 23.059

4.  AN ASSESSMENT OF THE AUGMENTED HISTAMINE TEST IN THE DIAGNOSIS OF PEPTIC ULCER. CORRELATIONS BETWEEN GASTRIC SECRETION, AGE AND SEX OF PATIENTS, AND SITE AND NATURE OF THE ULCER.

Authors:  J H BARON
Journal:  Gut       Date:  1963-09       Impact factor: 23.059
  4 in total
  3 in total

Review 1.  Medical management of peptic ulcer with reference to anti-ulcer agents in other gastro-intestinal diseases.

Authors:  D W Piper; T R Heap
Journal:  Drugs       Date:  1972       Impact factor: 9.546

2.  Deglycyrrhizinised liquorice: a report of its pharmacological properties and therapeutic efficacy in peptic ulcer.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1974       Impact factor: 9.546

3.  The controlled trial.

Authors:  R Doll
Journal:  Postgrad Med J       Date:  1984-11       Impact factor: 2.401
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.